 SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores
SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores
Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores
Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores
IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores
Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores 
              The Share Allotment Committee of Sandu Pharmaceuticals Limited met today and considered and approved the conversion of the 02nd tranche of warrants into Equity Shares at a price of Rs.20.69 per share (Face Value Rs.10/- and Premium Rs.10.69 per share) in accordance with the terms of issue of warrants. Accordingly, 8,89,667 equity shares has been allotted to the persons upon conversion of the warrants held by them.
The Committee also noted that the total subscription money of Rs.20.69 per share has been brought in for the above 8,89,667 Equity Shares.
Shares of SANDU PHARMACEUTICALS LTD. was last trading in BSE at Rs. 57.25 as compared to the previous close of Rs. 57.00. The total number of shares traded during the day was 2060 in over 23 trades.
The stock hit an intraday high of Rs. 58.40 and intraday low of 56.50. The net turnover during the day was Rs. 117969.00.